Indiana Board of Pharmacy v. Crick

433 N.E.2d 32, 1982 Ind. App. LEXIS 1129
CourtIndiana Court of Appeals
DecidedMarch 24, 1982
Docket2-481A121
StatusPublished
Cited by6 cases

This text of 433 N.E.2d 32 (Indiana Board of Pharmacy v. Crick) is published on Counsel Stack Legal Research, covering Indiana Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Indiana Board of Pharmacy v. Crick, 433 N.E.2d 32, 1982 Ind. App. LEXIS 1129 (Ind. Ct. App. 1982).

Opinion

YOUNG, Judge.

The appellant Indiana Board of Pharmacy appeals the trial court’s judgment which reversed in part the Board’s decision to revoke Curtis Ray Crick’s license to practice pharmacy. On appeal, the Board argues that the court erred in concluding that 1) the Board had found Crick guilty of an infraction not charged; 2) the Board had attempted to exercise criminal jurisdiction thereby violating constitutional rights; 3) there was no substantial, reliable, and probative evidence in the record to support the Board’s conclusion that Crick misbranded a drug in violation of Ind.Code 16-1-30-5 and 9; and 4) the Board acted arbitrarily and capriciously when it originally found Crick in violation of six different provisions and amended its finding essentially to that Crick failed to label a prescription and then imposed the same penalty as it had for the six violations.

We affirm.

The evidence indicates that prior to the incident in question Crick was a licensed pharmacist. On February 25, 1978, while working at Hook’s Drug Store # 42, Vernal Troxell approached Crick to have his prescription refilled. Troxell told Crick he had lost or misplaced the prescription bottle; however, he would bring it in when he found it so Crick could record the prescription number. Troxell had lost his prescription on other occasions. When he had found it, he brought it to Crick to record the prescription number and other neces *34 sary information. Crick refilled the prescription without the bottle and prescription number, giving Troxell 60 tablets of Empi-rin Compound No. 4 with codeine in an unlabeled bottle. Security officers witnessed the transaction and stopped Troxell to interrogate him. The officers recovered the tablets and the unlabeled bottle.

Based on this incident, the Indiana Board of Pharmacy sought to discipline Crick under Ind.Code 25-26-13-26. 1 In its notice, the Board alleged that Crick had: 1) distributed a Schedule III controlled substance without proper authorization contrary to I.C. 35-48-4-2 and 2) contrary to Regulation 6.21(A); 3) refilled a Schedule III controlled substance without proper authorization contrary to Regulation 6.22; 4) dispensed a Schedule III controlled substance without proper labeling contrary to Regulation 6.24; 5) made up an invalid prescription and dispensed a legend drug contrary to I.C. 16-6-8-3.5(a)(c); 6) kept improper records contrary to Regulation 304.04(d)(2); 7) failed to keep complete records contrary to Title 21, Code of Federal Regulations 1304.24; and 8) failed to label a drug delivered to an unauthorized person contrary to I.C. 16-1-30-5 and 9. After the Board heard evidence, it incorporated the charges into its findings and found that Crick had committed all violations as charged, except for the sixth and seventh charges which were deleted at the hearing. Based on their findings, the Board suspended Crick’s license for six months, fined him one thousand dollars, and placed him on probation for 360 days after the suspension was removed.

On receipt of the Board’s order, Crick petitioned for judicial review and filed a motion for remand for entry of specific findings. The court ordered the cause remanded and the Board amended its findings and conclusions as follows:

“Rhetorical paragraphs 1, 2, 3, 4, 5, and 8 of the Findings of Fact of the Indiana Board of Pharmacy in this matter [all previous findings], which are the subject of the above-described judicial review, are hereby withdrawn and replaced by the following amendments to read:
1. Curtis Ray Crick is a licensed pharmacist under the laws of the State of Indiana, having pharmacist license number 11336, and was so licensed on February 25, 1978.
2. On February 25, 1978, Vernal Tro-xell entered the Hook Drug Store at Southway Plaza in Muncie, Indiana, while the respondent, Curtis Ray Crick, was a pharmacist on duty at the said store, and secured from respondent a bottle containing tablets of Empirin Compound with Codeine Phosphate No. 4, a Schedule III controlled substance that had no identification affixed to it which identified its contents as Empirin Compound with Codeine Phosphate No. 4.
3. That the said bottle also had none of the following information:
a. the pharmacy name and address of Hooks at Southway Plaza;
b. the serial number and date of the filling of the bottle;
c. the name of Vernal Troxell;
d. the name of a doctor;
e. directions for use of the contents of the bottle;
*35 f. the statement “Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed”;
g. the name and place of business of the manufacturer, packer, or distributor of the contents;
h. an accurate statement of the quantity of the contents of said bottle in terms of weight, measure, and numerical count.
CONCLUSIONS OF LAW
1. Curtis Ray Crick did knowingly, intentionally, and unlawfully dispense a Schedule III controlled substance without proper labeling affixed to the package, contrary to Regulation 6.24 pertaining to the Indiana Uniform Controlled Substances Act, I.C. 25-26-13-26 of the Pharmacy Practice Act, Regulation 20 of the Pharmacy Practice Act Regulations and subject to discipline by terms of I.C. 25-26-13-26.
2. Curtis Ray Crick failed to label a drug in any manner required by I.C. 16-1-30-5 and I.C. 16-1-30-9, contrary to I.C. 25-26-13-26 of the Pharmacy Practice Act, Regulation 20 of the Pharmacy Practice Act Regulations and subject to discipline by terms of I.C. 25-26-13-26.”

The Board imposed the same discipline as it had originally assessed.

After reviewing the record and these new findings, the trial court made its findings setting out the Board’s findings and its own standard of review under I.C. 4-22-1-18. 2 It then prepared its own additional findings and conclusions:

“16. ... The Court further finds that the conclusion reached by the Indiana Board of Pharmacy in its amended conclusion as set forth above was that Curtis Ray Crick did dispense a bottle of Empirin Compound with Codeine Phosphate No. 4 without a label which the Board concluded was in violation of:
(a) I.C. 16-1-30-5
(b) I.C. 16-1-30-9
(c) Rule 20 of the Indiana Board of Pharmacy
(d) Regulation 6.24 of the Indiana Board of Pharmacy
The Court further finds that violation of I.C. 16-1-30-5 and I.C. 16-1-30-9 are by statute (I.C. 16-1-28-17) misdemeanors and that jurisdiction to try misdemeanors is contained within I.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Carter v. Carolina Tobacco Co., Inc.
873 N.E.2d 611 (Indiana Court of Appeals, 2007)
Indiana State Board of Education v. Brownsburg Community School Corp.
865 N.E.2d 660 (Indiana Court of Appeals, 2007)
State v. Carmel Healthcare Management, Inc.
660 N.E.2d 1379 (Indiana Court of Appeals, 1996)
COUNTY DPW v. Deaconess Hosp.
588 N.E.2d 1322 (Indiana Court of Appeals, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
433 N.E.2d 32, 1982 Ind. App. LEXIS 1129, Counsel Stack Legal Research, https://law.counselstack.com/opinion/indiana-board-of-pharmacy-v-crick-indctapp-1982.